Codon 72 polymorphism of TP53 gene is a novel prognostic marker for therapy in multiple myeloma

Br J Haematol. 2014 Jun;165(5):728-31. doi: 10.1111/bjh.12784. Epub 2014 Feb 24.
No abstract available

Keywords: codon 72 polymorphism of TP53; multiple myeloma; prognosis; thalidomide.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Codon / genetics
  • Female
  • Genes, p53 / genetics*
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Multiple Myeloma / genetics*
  • Polymorphism, Genetic
  • Prognosis
  • Treatment Outcome

Substances

  • Codon